Levodopa/benserazide

( DrugBank: Levodopa, Benserazide / KEGG DRUG: Levodopa, Benserazide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	15

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 10 of 15 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000039201	2020-11-15	2020-10-21	Pharmacology of levodopa/carbidopa versus levodopa/benserazide in patients with parkinson's disease	Pharmacology of levodopa/carbidopa versus levodopa/benserazide in patients with parkinson's disease	Parkinson's disease	A:phase I: levodopa/carbidopa; phase II: levodopa/benserazide;B:phase I: levodopa/benserazide; phase ...	The Affiliated Brain Hospital of Nanjing Medical University (Nanjing Brain Hospital)	NULL	Recruiting	30	85	Both	A:10;B:10;	Phase 4	China
2	NCT02769793 (ClinicalTrials.gov)	June 2015	9/5/2016	Efficacy of Levodopa/BenserazideDispersible Tablet on Response Fluctuations in PD Patients With Dela ...	Efficacy of Levodopa/BenserazideDispersible Tablet on Response Fluctuations in Parkinson's Disease P ...	Parkinson Disease	Drug: Levodopa dispersible;Drug: Levodopa	Seoul National University Hospital	SMG-SNU Boramae Medical Center;Samsung Medical Center	Completed	31 Years	80 Years	All	40	Phase 4	Korea, Republic of
3	NCT01568047 (ClinicalTrials.gov)	February 2010	29/3/2012	Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients	Multicentre, Double-blind, Randomised, Placebo-controlled Study in Four Parallel Groups of PD Patien ...	Parkinson's Disease	Drug: Placebo;Drug: BIA 9-1067;Drug: Levodopa/Carbidopa;Drug: Levodopa/Benzerazide	Bial - Portela C S.A.	NULL	Completed	30 Years	N/A	All	40	Phase 2	Romania;Ukraine
4	NCT02169414 (ClinicalTrials.gov)	February 2010	24/1/2012	Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetic ...	Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetic ...	Parkinson's Disease (PD)	Drug: BIA 9-1067 5 mg;Drug: BIA 9-1067 25 mg;Drug: levodopa/carbidopa 100/25;Drug: Placebo;Drug: lev ...	Bial - Portela C S.A.	NULL	Completed	18 Years	45 Years	All	74	Phase 1	France
5	NCT01533116 (ClinicalTrials.gov)	March 2009	24/1/2012	Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Bens ...	Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of a Single-dose of Immediate-release 1 ...	Parkinson Disease	Drug: BIA 9-1067;Drug: Placebo;Drug: levodopa/carbidopa;Drug: levodopa/benserazide	Bial - Portela C S.A.	NULL	Completed	25 Years	45 Years	All	52	Phase 1	Canada
6	NCT02169466 (ClinicalTrials.gov)	January 2009	20/1/2012	Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a ...	Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a ...	Parkinson's Disease (PD)	Drug: BIA 9-1067;Drug: Placebo;Drug: Madopar® HBS	Bial - Portela C S.A.	NULL	Completed	18 Years	45 Years	Male	22	Phase 1	Portugal
7	NCT02169895 (ClinicalTrials.gov)	September 2008	20/1/2012	Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a ...	Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-10 ...	Parkinson's Disease (PD)	Drug: BIA 9-1067;Drug: Placebo;Drug: Prolopa®	Bial - Portela C S.A.	NULL	Completed	25 Years	45 Years	Male	16	Phase 1	Canada
8	EUCTR2006-001793-24-PT (EUCTR)	07/11/2006	31/07/2006	A MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, ACTIVE- AND PLACEBO-CONTROLLED TRIAL TO INVESTIGATE THE EFF ...	A MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, ACTIVE- AND PLACEBO-CONTROLLED TRIAL TO INVESTIGATE THE EFF ...	Patients with idiopathic Parkinson’s disease (PD) and with end-of-dose deterioration (wearing-off) p ...	Product Name: Nebicapone Product Code: BIA 3-202 Trade Name: COMTAN® Product Name: Entacapone INN or Pro ...	BIAL - Portela & Cª, SA	NULL	Not Recruiting			Female: yes Male: yes	250		Portugal;Austria
9	NCT03103399 (ClinicalTrials.gov)	September 26, 2006	28/3/2017	Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With Wearingoff Phenomenon	A Multicentre, Double-blind, Randomised, Active- and Placebo-controlled Trial to Investigate the Eff ...	Parkinson Disease	Drug: Comtan®;Drug: Nebicapone;Drug: Levodopa/DDCI;Drug: Placebo	Bial - Portela C S.A.	NULL	Completed	30 Years	80 Years	All	254	Phase 2	NULL
10	EUCTR2006-001793-24-AT (EUCTR)	31/07/2006	24/07/2006	A MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, ACTIVE- AND PLACEBO-CONTROLLED TRIAL TO INVESTIGATE THE EFF ...	A MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, ACTIVE- AND PLACEBO-CONTROLLED TRIAL TO INVESTIGATE THE EFF ...	Patients with idiopathic Parkinson’s disease (PD) and with end-of-dose deterioration (wearing-off) p ...	Product Name: Nebicapone Product Code: BIA 3-202 Product Name: Entacapone INN or Proposed INN: Entacapo ...	BIAL - Portela & Cª, SA	NULL	Not Recruiting			Female: yes Male: yes	250		Portugal;Austria

First Previous1 2Next Last